Clinical Trial Update: 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a study of the radiotracer 68Ga-grazytracer PET to help distinguish pseudoprogression from true progr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 68Ga-grazytracer

Snippet

Sponsor: Ruijin Hospital | Conditions: PET / CT, Lung Carcinoma | Status: RECRUITING